OLOPATADINE HYDROCHLORIDE
- Product NDC
- 62332-774
- 11-digit product format
- 623320774
- Labeler code
- 62332
- Product ID
- 62332-774_16459925-7e27-4483-a0a5-0105f00c7648
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- OLOPATADINE HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Labeler
- Alembic Pharmaceuticals Inc.
- Application
- ANDA217856
- Marketing category
- ANDA
- Marketing start
- 2026-11-03
- Substance
- OLOPATADINE HYDROCHLORIDE
- Active strength
- 7 mg/mL
- Pharmacologic classes
- Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217856-001 | OLOPATADINE HYDROCHLORIDE | OLOPATADINE HYDROCHLORIDE | EQ 0.7% BASE | SOLUTION/DROPS / OPHTHALMIC | 2026-11-03 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A217856-001 | OLOPATADINE HYDROCHLORIDE | EQ 0.7% BASE | SOLUTION/DROPS / OPHTHALMIC | 2026-11-03 | d4dbc9d85df4… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OLOPATADINE HYDROCHLORIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OLOPATADINE HYDROCHLORIDE | 7 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2XG66W44KF | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| fa036dac-64e0-4bd0-8100-7ef31b736053 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OLOPATADINE HYDROCHLORIDE | OLOPATADINE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | fa036dac-64e0-4bd0-8100-7ef31b736053 | 2026-11-04 | Warnings | 217856 ANDA217856 62332-774 |
| OLOPATADINE HYDROCHLORIDE | OLOPATADINE HYDROCHLORIDE | Alembic Pharmaceuticals Limited | e097611b-5b2d-471a-8bce-81ffbe9e58a5 | 2026-11-04 | Warnings | 217856 ANDA217856 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 62332-774-25 | 62332077425 | 1 BOTTLE in 1 CARTON (62332-774-25) / 2.5 mL in 1 BOTTLE | 1 bottle | 2026-11-03 | No | No | Current |